Hagersten, Sweden

Andreas Castan

This inventor holds 2 USPTO granted patents. Top assignee: Pharmacia Ab. Active years: 2004-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Castan. Retrieved from https://idiyas.com/inventor/andreas-castan-pnp3ugas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 1.5

ph-index = 2

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 2004-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Andreas Castan in Recombinant Peptide Production

Introduction

Andreas Castan is a notable inventor based in Hagersten, Sweden. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant peptides. With a total of 2 patents, his work has advanced the methods used in peptide synthesis.

Latest Patents

Andreas Castan's latest patents include a method for the production of recombinant peptides with a low amount of trisulfides. This innovative method involves fermenting cells to produce recombinant peptides. A metal salt is added to a concentrate of the fermented cells after the fermentation step, prior to peptide isolation. The pH of the cell concentrate after the addition of the metal salt is maintained at less than or equal to 7, which effectively reduces the amount of trisulfides formed during the production process. Notably, this production method does not include the conversion of formed trisulfide peptides into their native peptide form after the addition of the metal salt. In one embodiment, the recombinant peptide produced is recombinant growth hormone.

Another significant patent by Castan relates to the production of peptides through fed-batch cultivation of a microorganism in a bioreactor. This method utilizes a medium comprising an organic carbon source, nitrogen source, and mineral salts. The cultivation process is enhanced by the addition of the organic carbon source through oscillation feed and/or variation of stirring speed, such as in a square or sinus wave pattern. In this case, glucose is preferred as the organic carbon source, and the recombinant peptide produced is also growth hormone.

Career Highlights

Andreas Castan has been associated with Pharmacia AB, where he has applied his expertise in biotechnology to develop innovative solutions in peptide production. His work has been instrumental in improving the efficiency and effectiveness of recombinant peptide synthesis.

Collaborations

Some of his notable coworkers include Barbro Hemmendorff and Anders Persson, who have collaborated with him on various projects within the company.

Conclusion

Andreas Castan's contributions to the field of recombinant peptide production have been significant, with his innovative methods paving the way for advancements in biotechnology. His patents reflect a deep understanding of the complexities involved in peptide synthesis, showcasing his role as a leading inventor in this domain.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…